International Symposium on Intensive Care and Emergency Medicine: Pre-symposium courses

Pre-symposium courses

Location: Square Brussels Meeting Center
Chairmen: Jan De Waele (Ghent, Belgium), Jeroen Schouten (Nijmegen, Netherlands)
Date(s):  19/3/2018
Price per participant: 
225 Eur
  • 8:30 Welcome and registration
  • 9:00 Therapeutic drug monitoring in ICU
    • Theory – Jan De Waele (Ghent, Belgium)
    • This is how I do it – Lennie Derde (Utrecht, Netherlands)
  • 10:00 Who is at risk of MDR infections? How does that influence my empirical therapy?
    • Theory – Jean-Francois Timsit (Paris, France)
    • This is how I do it – Tony Whitehouse (Birmingham, UK)
  • 11:00 Break
  • 11:15 De-escalation of antibiotic therapy and safely reducing antibiotic duration
    • Theory – Jeroen Schouten (Nijmegen, Netherlands)
    • This is how I do it – Jan De Waele (Ghent, Belgium)
  • 12:15 Lunch
  • 13:15 State of the art lecture
    • - Review of antimicrobial treatment of neurological infections (meningitis, brain abscess, encephalitis) in immunocompetent ICU patients
      Romain Sonneville (Paris, France)
  • 14:00 Clinical cases and workshops in rotating groups (30’ each)
    • How to create and implement an AB stewardship program in my own ICU?  
    • Jeroen Schouten (Nijmegen, the Netherlands)

    • How to manage dosing of antibiotics during a complicated ICU stay (CRRT, ECMO, etc)?
    • Tony Whitehouse (Birmingham, UK)

    • Clinical case study 1*, a patient with abdominal sepsis, AKI and (possibly) a fungal infection
    • Lennie Derde (Utrecht, Netherlands)

    • Clinical case study 2*: a patient colonized with multidrug resistant pathogens and acute respiratory failure
    • Jean-Francois Timsit (Paris, France)
  • 16:00  End

in these clinical cases, diagnostic and therapeutic management is discussed from admission to discharge in S’s: Start (empirical therapy, timeliness, cultures, rapid diagnostic tests, documentation) Safety (allergy, interactions, adapting to renal function) Streamline  (re-evaluation, de-escalation, IV-oral switch, PK-PD alterations) and Stop (duration of therapy)